Bristol-Myers Squibb Co (BMY) EPS Estimated At $0.75

  • Bristol-Myers Squibb
  • 13/10/2017
Bristol-Myers Squibb Co (BMY) EPS Estimated At $0.75
Bristol-Myers Squibb Company (NYSE:BMY)'s stock had its "sell" rating reiterated by equities researchers at BMO Capital Markets in a research note issued to investors on Thursday.

Tracking some recent stock price action, we can see that Bristol-Myers Squibb Company (BMY) recently touched 65.31. S&CO Inc. now owns 391,567 shares of the biopharmaceutical company's stock valued at $21,818,000 after buying an additional 6,701 shares in the last quarter. The stock rose 0.14% or $0.09 reaching $65.2 per share. About 2.59M shares traded. It has underperformed by 39.89% the S&P500.

Analysts await Bristol-Myers Squibb Co (NYSE:BMY) to report earnings on October, 26 before the open. KEMET Corporation (NYSE:KEM) earnings have declined with a quarterly rate of -3.9% over the last 5 years. BMY's profit will be $1.23B for 21.70 P/E if the $0.75 EPS becomes a reality. Pictet Retail Bank & Tru Limited holds 0.07% in Bristol-Myers Squibb Co (NYSE:BMY) or 4,000 shares. Of the analysts who provided ratings, 6 rated the company a Hold, 1 rated it a Strong Sell, 1 rated it a Moderate Buy, and 5 rated it a Strong Buy. Therefore 32% are positive. The stock of Bristol-Myers Squibb Co (NYSE:BMY) has "Hold" rating given on Monday, August 14 by Cowen & Co. The firm has "Equal-Weight" rating given on Wednesday, July 13 by Barclays Capital. The stock of Bristol-Myers Squibb Co (NYSE:BMY) has "Buy" rating given on Wednesday, August 23 by Jefferies. The company was downgraded on Tuesday, September 12 by Hilliard Lyons. The firm has "Underperform" rating given on Friday, July 28 by BMO Capital Markets. The rating was maintained by Credit Suisse on Monday, May 9 with "Outperform".

Investors sentiment decreased to 0.95 in Q2 2017. Its up 0.03, from 0.93 in 2017Q1. It dropped, as 78 investors sold BMY shares while 520 reduced holdings. 120 funds opened positions while 451 raised stakes. Connecticut-based Wright has invested 0.16% in Bristol-Myers Squibb Co (NYSE:BMY). Deutsche Bank AG set a $55.00 target price on shares of Bristol-Myers Squibb and gave the company a "hold" rating in a report on Monday, July 17th. M&T Bancorp, a New York-based fund reported 1.68M shares. Mcgowan Group Asset Management holds 0.04% or 3,622 shares.

ILLEGAL ACTIVITY WARNING: "Bristol-Myers Squibb's (BMY) Sell Rating Reaffirmed at BMO Capital Markets" was reported by Week Herald and is the property of of Week Herald.

The collective rating of 2.5 for Bristol-Myers Squibb Company (NYSE:BMY) also leans strongly towards the neutral end of the spectrum.

Bristol-Myers Squibb Company (NYSE:BMY) now has an Average Broker Rating of 2.23. 248,000 were reported by Sphera Funds Management Limited. Federated Invsts Pa holds 15,949 shares or 0% of its portfolio. Gotham Asset Mgmt Ltd Company holds 87,459 shares. Following the completion of the sale, the senior vice president now owns 46,297 shares of the company's stock, valued at approximately $2,777,820. Alabama-based Retirement System Of Alabama has invested 0.01% in Mercury General Corporation (NYSE:MCY).

Bp Plc decreased Lyondellbasell Indu Cl A (LYB) stake by 31.58% reported in 2017Q2 SEC filing. Salient Advisors Ltd Co holds 7,750 shares. Spdr Barclays Capital High Yield Bond Et (JNK) was raised too.

Among 18 analysts covering Phillips 66 (NYSE:PSX), 8 have Buy rating, 0 Sell and 10 Hold. Therefore 33% are positive. LyondellBasell had 52 analyst reports since September 1, 2015 according to SRatingsIntel. The company was maintained on Thursday, August 27 by Jefferies. Also, Director Theodore R. Samuels II bought 6,000 shares of the stock in a transaction on Wednesday, August 2nd. UBS has "Buy" rating and $75 target. The company was maintained on Friday, April 7 by Wood. The firm has "Buy" rating by UBS given on Friday, August 19. Keefe Bruyette & Woods maintained Walker & Dunlop, Inc. The rating was upgraded by Guggenheim on Wednesday, December 2 to "Buy".

Investors sentiment decreased to 1.51 in 2017 Q2. Its down 0.03, from 0.98 in 2017Q1. 17 funds opened positions while 59 raised stakes. Wells Fargo Mn holds 0% of its portfolio in Oclaro Inc (NASDAQ:OCLR) for 499,863 shares. (NYSE:WD) for 186,451 shares. This is the signal from the 100-day MA which is used to gauge changes in stock price. Stralem Incorporated has 50,400 shares for 0.33% of their portfolio. The percentage of shares being held by the company management was 0.2% while institutional stake was 71.1%. Private Wealth Advisors stated it has 4,916 shares. Archford Strategies Ltd reported 0.23% of its portfolio in LyondellBasell Industries NV (NYSE:LYB). Texas Yale Capital Corp accumulated 0.08% or 15,625 shares. Commonwealth Equity Serv Inc invested in 0.25% or 701,592 shares. 1,377 are owned by Endurance Wealth Management. Parametric Portfolio Lc has invested 0% in Oclaro Inc (NASDAQ:OCLR). (NYSE:WD) for 35,000 shares. Sg Cap Limited Liability Company stated it has 1.56 million shares. Td Asset Mngmt Incorporated invested in 0.08% or 953,676 shares. Wellington Mngmt Group Inc Llp has invested 0.02% of its portfolio in Oclaro Inc (NASDAQ:OCLR).
  
Or use your account on Blog

Error message here!

Hide Error message here!

Forgot your password?

Or register your new account on Blog

Error message here!

Error message here!

Hide Error message here!

Lost your password? Please enter your email address. You will receive a link to create a new password.

Error message here!

Back to log-in

Close